JEFFREY GITT, D.O.
Neurology Physician · PHOENIX, AZ
Individual Active NPI 1831370741
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 104 | 76,934 | $8,320,806 | $2,797,000 | $2,225,496 |
| 2023 | 119 | 69,533 | $8,380,581 | $3,135,174 | $2,495,045 |
| 2022 | 267 | 83,798 | $9,758,862 | $3,460,143 | $2,753,395 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2350 | Injection, ocrelizumab, 1 mg | 13,800 | $41 | $33 |
| J0875 | Injection, dalbavancin, 5 mg | 5,100 | $15 | $12 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 700 | $0 | $0 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 309 | $57 | $44 |
| 96372 | Injection of drug or substance under skin or into muscle | 96 | $14 | $11 |
| 96375 | Injection of additional new drug or substance into vein | 91 | $14 | $11 |
| 96415 | Administration of chemotherapy into vein, each additional hour | 58 | $25 | $20 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 45 | $118 | $91 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 36 | $1 | $1 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 26 | $6 | $4 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Neurology Physician | 2084N0400X | ✓ | 2023 | AZ |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Neurology Physician providers in Arizona
- NPI 1548203573
- NPI 1356977219
- NPI 1124296983
- NPI 1427368885
- NPI 1790245520
- NPI 1417395799
- NPI 1679771950
- NPI 1063953248
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.